For: | Chen TT, Lv JJ, Chen L, Li M, Liu LP. Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis. World J Gastroenterol 2023; 29(35): 5154-5165 [PMID: 37744293 DOI: 10.3748/wjg.v29.i35.5154] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i35/5154.htm |
Number | Citing Articles |
1 |
Di Chen, Lin-Jun Wang, Hong-Lei Li, Fei Feng, Jian-Chun Li, Liping Liu. Progress of heparanase in septic cardiomyopathy: A review. Medicine 2024; 103(33): e38901 doi: 10.1097/MD.0000000000038901
|
2 |
Di Chen, Honglei Li, Shitao Huang, Zhongya Huang, Yibo Sun, Liping Liu. Heparanase inhibitor improves clinical study in patients with septic cardiomyopathy. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1429109
|
3 |
Tingting Tan, Jiajie Li, Wensi Fan, Kangni Shang, Chujun Yang, Xiaohao Liu, Shihui Zhu, Tong Liu, Junjie Wang, Yingchuan Li, Yunfeng Lin. Tetrahedral Framework Nucleic Acid Relieves Sepsis‐Induced Intestinal Injury by Regulating M2 Macrophages. Cell Proliferation 2025; doi: 10.1111/cpr.13803
|